Argenx NV Ownership

ARGX Stock

USD 564.59 8.12 1.42%

Argenx NV holds a total of 61.2 Million outstanding shares. Over half of Argenx NV's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Shares in Circulation

First Issued

2013-03-31

Previous Quarter

71 M

Current Value

65.7 M

Avarage Shares Outstanding

36.1 M

Quarterly Volatility

18.9 M

Yuan Drop

Covid

Some institutional investors establish a significant position in stocks such as Argenx NV in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Argenx NV, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Market Cap Enterprise Value

Build AI portfolio with Argenx Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in argenx NV ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Argenx Stock Ownership Analysis

About 56.0% of the company shares are held by institutions such as insurance companies. The company recorded earning per share (EPS) of 16.37. argenx NV ADR had not issued any dividends in recent years. argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Ltd, Universit Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands. Argenx Se is traded on NASDAQ Exchange in the United States. For more info on argenx NV ADR please contact EMBA MBA at 31 10 703 8441 or go to https://argenx.com.

Argenx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Argenx NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading argenx NV ADR backward and forwards among themselves. Argenx NV's institutional investor refers to the entity that pools money to purchase Argenx NV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Citadel Advisors Llc	2025-03-31	551.9 K
Wellington Management Company Llp	2025-03-31	406.2 K
Amvescap Plc.	2025-03-31	382.7 K
Sei Investments Co	2025-03-31	361 K
Bank Of America Corp	2025-03-31	340.1 K
Lord, Abbett & Co Llc	2025-03-31	274.7 K
Millennium Management Llc	2025-03-31	268.6 K
D. E. Shaw & Co Lp	2025-03-31	260.3 K
Jennison Associates Llc	2025-03-31	249.5 K
Fmr Inc	2025-03-31	5.7 M
T. Rowe Price Associates, Inc.	2025-03-31	5.4 M

Note, although Argenx NV's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Argenx NV Outstanding Bonds

Argenx NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. argenx NV ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Argenx bonds can be classified according to their maturity, which is the date when argenx NV ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	ARES 4125 30 JUN 51 Corp Bond US04018VAA17	View
	US040133AA87 Corp Bond US040133AA87	View
	ARES CAPITAL PORATION Corp Bond US04010LBA08	View
	ARES CAPITAL PORATION Corp Bond US04010LBB80	View
	BNP Paribas FRN Corp Bond USF1R15XK367	View
	ARCC 32 15 NOV 31 Corp Bond US04010LBC63	View
	ARCC 2875 15 JUN 27 Corp Bond US04010LBD47	View
	ARES CAPITAL PORATION Corp Bond US04010LAY92	View

View All Argenx NV Corporate Bonds

Argenx NV Corporate Filings

6K	30th of June 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.	View Verify
	12th of February 2025 Other Reports	View Verify
13A	14th of November 2024 An amended filing to the original Schedule 13G	View Verify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A

Additional Tools for Argenx Stock Analysis

When running Argenx NV's price analysis, check to measure Argenx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argenx NV is operating at the current time. Most of Argenx NV's value examination focuses on studying past and present price action to predict the probability of Argenx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argenx NV's price. Additionally, you may evaluate how the addition of Argenx NV to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC